RxDoctor Payments Data

Valmarie Ramos, MD

Hematology & Oncology · Egg Harbor Township, NJNPI 1861724106

Payments from drug & device makers

$12,912in general payments, 2019–2025

Across 614 payments — averaging $21.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$3K
  • E.r. Squibb & Sons, L.L.C.$774
  • AbbVie$736
  • AstraZeneca$729
  • Johnson & Johnson$554
  • Seagen Inc.$551
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$9,69175%
  • Education$7226%
  • Other$2,49819%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis69$3,134
E.r. Squibb & Sons, L.L.C.52$774
AbbVie21$736
AstraZeneca(2 entities)43$729
Johnson & Johnson31$554
Seagen Inc.25$551
Pfizer31$519
Pharmacyclics LLC, An Abbvie Company12$336
Bristol Myers Squibb22$330
Daiichi Sankyo Inc.19$314
Incyte Corporation22$305
Bayer18$294
Lilly USA, LLC15$290
Genentech USA, Inc.18$274
Taiho Oncology, Inc.13$263
Merck16$259
AVEO Pharmaceuticals, Inc.6$250
Astellas Pharma US Inc16$242
Eisai Inc.14$237
Gilead(2 entities)15$237
GSK11$194
Pharmacosmos Therapeutics Inc.10$174
Genmab U.S., Inc.7$116
Takeda Pharmaceuticals U.S.A., Inc.6$115
Mirati Therapeutics, Inc.6$111
ADC Therapeutics America, Inc.5$101
Array Biopharma Inc6$97
Amgen7$97
Sumitomo Pharma America, Inc.6$94
Tempus AI, Inc5$91
Geron Corporation5$84
Beigene USA, Inc.5$79
Foundation Medicine, Inc.5$75
Myovant Sciences Inc.5$69
Morphosys, US Inc.5$65
Puma Biotechnology, Inc.4$62
Dendreon Pharmaceuticals LLC3$57
Beone Medicines USA, Inc.3$52
Regeneron Healthcare Solutions, Inc.3$50
Sanofi3$49
Exelixis Inc.3$44
EMD Serono, Inc.2$43
Servier Pharmaceuticals LLC2$35
Agios Pharmaceuticals, Inc.1$32
Boehringer Ingelheim2$29
Sobi, Inc2$27
Emmaus Medical, Inc.1$27
Immunocore Limited1$26
Menarini Silicon Biosystems, Inc.1$22
Stemline Therapeutics Inc.1$21
Karyopharm Therapeutics Inc.1$18
Acrotech Biopharma Inc.1$17
GE HealthCare1$16
Pharmaessentia USA Corporation1$16
Recordati_rare_diseases_inc.1$16
Blueprint Medicines Corporation1$15
Jazz Pharmaceuticals Inc.1$14
Tesaro, Inc.1$14
Ipsen Biopharmaceuticals, Inc1$13
Rigel Pharmaceuticals, Inc.1$9

How this compares

$12,912 in reported general payments places this provider in the 55th percentile of 362 hematology & oncology providers in New Jersey.

See all hematology & oncology providers in New Jersey

Medicare billing

Part B allowed, 2024
$92,521
Medicare patients
337
Services billed
790

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Egg Harbor Township

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →